Avellino Labs has developed a unique DNA Test for LASIK and Refractive Surgery Safety. The company’s patent protected test provides fast, accurate and affordable results. It screens for GCD1, GCD2, Lattice, Reis-Bucklers, and Thiel Behnke Corneal Dystrophies. Based on the tests results, patients and physicians can make informed decisions when considering vision correction surgery. Buccal swab analysis is performed in our CLIA certified lab in Menlo Park, California and has been qualified as 100% accurate with no false positives in clinical trials.
PLJ Marketing is constantly looking for new Ophthalmic technologies including Genetic Testing, Gene Therapy and New Dry Eye devices. Contact us for more information.
Practice or Distributor Marketing
Email, Internet and social media are affordable ways to connect with your audience. How effective are your email campaigns, website management and social media campaigns?
email@example.com | 214.356.4427
Contact us about the latest in products and other ophthalmic resources.
firstname.lastname@example.org | 940.395.7766
Mergers & Acquisitions
As an aspect of strategic management, M&A can allow enterprises to grow, shrink and change the nature of their business or competitive position. Whether you would like to increase the value or sell, contact us.
*Doug Hook works collaboratively with RMelander & Associates, Bayou Ophthalmic and other approved companies representing new and pre-owned equipment.
The Avellino DNA Test for LASIK Safety has been recognized as transformative global health technology by The World Economic Forum (WEF) which named Avellino Labs a 2015 Technology Pioneer (view here). Avellino Labs was selected based on its unique story and potential to transform and impact global health. Past recipients include Google (2001), Wikimedia (2007), Mozilla (2007), Kickstarter (2011) and Dropbox (2011). Avellino News & Press Releases